Stock Analysis

Humana First Quarter 2024 Earnings: EPS: kr0.44 (vs kr1.07 in 1Q 2023)

OM:HUM
Source: Shutterstock

Humana (STO:HUM) First Quarter 2024 Results

Key Financial Results

  • Revenue: kr2.41b (down 1.1% from 1Q 2023).
  • Net income: kr21.0m (down 59% from 1Q 2023).
  • Profit margin: 0.9% (down from 2.1% in 1Q 2023).
  • EPS: kr0.44 (down from kr1.07 in 1Q 2023).
earnings-and-revenue-growth
OM:HUM Earnings and Revenue Growth April 26th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Humana Earnings Insights

Looking ahead, revenue is forecast to stay flat during the next 3 years compared to a 11% growth forecast for the Healthcare industry in Sweden.

Performance of the Swedish Healthcare industry.

The company's shares are up 5.9% from a week ago.

Risk Analysis

What about risks? Every company has them, and we've spotted 3 warning signs for Humana (of which 1 is concerning!) you should know about.

Valuation is complex, but we're helping make it simple.

Find out whether Humana is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.